You are here
- Home
- Archive
- Volume 70, Issue 8
- Corrections
Article metrics
See original article:
- Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies - February 01, 2009
- Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis - January 01, 2009
- Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade - June 01, 2009
- Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study - July 01, 2009
- Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe - April 01, 2009
- Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis - May 01, 2009
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal - June 01, 2009
- Diagnosing axial spondyloarthropathy. The new Assessment in SpondyloArthritis international Society criteria: MRI entering centre stage - June 01, 2009
- Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence - November 01, 2009
- Adaptation and cross-cultural validation of the rheumatoid arthritis work instability scale (RA–WIS) - November 01, 2009
- MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib - September 01, 2009
- Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study - December 01, 2009
- Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients - December 01, 2009
- Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial - January 01, 2010
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009 - January 01, 2010
- A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools - February 01, 2010
- Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level - February 01, 2010
- Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy - February 01, 2010
- The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis - March 01, 2010
- Evidence for treating rheumatoid arthritis to target: results of a systematic literature search - April 01, 2010
- Treating rheumatoid arthritis to target: recommendations of an international task force - April 01, 2010
- PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population - April 01, 2010
- Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial) - March 01, 2010
- The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy - May 01, 2010
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs - June 01, 2010
- Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment - June 01, 2010
- Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive disease - June 01, 2010
- Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate - June 01, 2010
- Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: a 1-year observational study - July 01, 2010
- Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008 - March 01, 2010
- No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort - July 01, 2010
- Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population - August 01, 2010
- Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study - May 01, 2010
- Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? - September 01, 2010
- Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis - November 01, 2010
- Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study - November 01, 2010
- Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register - June 01, 2010
- The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus - February 01, 2009
- Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA - June 01, 2010
PDFMiscellaneous
Corrections
Corrections
Free
